GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the TEPC15-VK45.1 anti-2-phenyl-5-oxazolone NQ16- 113.8 scfv in complex with phoxgaba

Analyse Crystal structure of the TEPC15-VK45.1 anti-2-phenyl-5-oxazolone NQ16- 113.8… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2CJU
Type
protein
Length
234 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
NQ16-113.8 anti-phox antibody
Ligands
PHX
Pockets
3 · best druggability 0.39

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
HNQ16-113.8 anti-phox antibodyprotein12110% helix, 52% strand—
LNQ16-113.8 anti-phox antibodyprotein1133% helix, 48% strand—

Ligands and binding sites

  • PHX · 4-{[(Z)-(5-oxo-2-phenyl-1,3-oxazol-4(5H)-ylidene)methyl]amino}butanoic acid · ligand · chains H, L

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1870.390.7719PHX
2860.330.7322empty
3540.280.7418empty

Interfaces

1 interface between chains.

  • H–L · 894 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 2CJU · Crystal structure of the TEPC15-Vk45.1 anti-2-phenyl-5-oxazolone NQ16- 113.8 scFv in… · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.